However, side effects are dose-dependent, so expect more gastrointestinal effects at higher doses
Evidence supports GLP-1 drugs as potential AUD treatment Semaglutide showed robust but still preliminary effects on several somatic and alcohol-related outcomes in AUD treatment seekers with comorbid obesity
Incorrect procedures compromise experimental results and introduce potential hazards
Hence, logging doses, meals, fluids, blood pressure, and symptoms for two weeks reveals patterns clinicians can act on rather than relying on fragmented memory
The genetic test does not predict whether you will or will not develop migraines on GLP-1 medication
Effects of omega-3-6-9 fatty acid supplementation on behavior and sleep in preterm toddlers with autism symptomatology: secondary analysis of a randomized clinical trial